Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372782A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
11/16/2000CA2372738A1 Low-dose il-1.beta.-induced photoreceptor cell rescue without retinal dysplasia
11/16/2000CA2372714A1 The use of luteinizing hormone in the induction of pauci-or unifolliculogenesis
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372515A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000CA2371902A1 Novel nucleic acids and proteins with interferon-beta activity
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/16/2000CA2371265A1 Materials for soft tissue augmentation and methods of making and using same
11/16/2000CA2371193A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000CA2369594A1 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051976A2 Use of bisphosphate for the treatment of osteogenesis imperfecta
11/15/2000EP1051521A2 Method of screening therapeutic agents
11/15/2000EP1051503A1 METHOD FOR PRODUCING, BY PLANT CELLS, $g(a) 1?-ANTITRYPSIN AND ITS ALLELES, AND PRODUCTS CONTAINING THE RESULTING $g(a) 1?-ANTITRYPSIN
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051497A2 Human protein kinase molecules
11/15/2000EP1051495A2 Recombinant mistletoe lectines
11/15/2000EP1051494A1 Methods and reagents for decreasing allergic reactions
11/15/2000EP1051492A1 Recombinant proteins from hgf and msp
11/15/2000EP1051491A1 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF
11/15/2000EP1051490A2 Modulation of cell proliferation, methods and reagents
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051485A1 Trek-1 like two pore potassium channel
11/15/2000EP1051482A1 Cytotoxic heteromeric protein combinatorial libraries
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051433A2 Antimicrobial peptides
11/15/2000EP1051432A2 Method for reducing immunogenicity of proteins
11/15/2000EP1051431A1 Thrombin inhibitors
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051428A1 Human cystatin f
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP1051208A1 Hydrophilic coating for an intracorporeal medical device
11/15/2000EP1051204A2 Prostheses with associated growth factors
11/15/2000EP1051194A1 Process for making absorbable microparticles
11/15/2000EP1051191A2 Cd154 blockade therapy for pancreatic islet tissue transplantation
11/15/2000EP1051188A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
11/15/2000EP1051187A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/15/2000EP1051160A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
11/15/2000EP1051157A2 Controlled release delivery of peptide or protein
11/15/2000EP1051141A1 Amylin agonist pharmaceutical compositions containing insulin
11/15/2000EP1011694A4 Conditioning for allogeneic stem cell transplantation
11/15/2000EP0817795B1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0717635B1 Methods for regulating gastrointestinal motility
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/15/2000EP0691847B1 Use of aspirin for the manufacture of a medicament for enhancing uterine blood perfusion
11/15/2000EP0686045B1 Excipient stabilization of polypeptides treated with organic solvents
11/15/2000EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
11/15/2000EP0650371B1 Covalent polar lipid-peptide conjugates for biological targeting
11/15/2000EP0601129B1 Morphogenic protein screening method
11/15/2000CN1273604A Antifreeze proteins, DNA and expression system
11/15/2000CN1273534A Method for treating neurological deficits
11/15/2000CN1273533A I (Robinia Pseudoacacia) lectin and its uses
11/15/2000CN1273274A Process for preparing natto kinase and its application
11/15/2000CN1273127A Genetically engineered body for preparing somatostatin subunit vaccine
11/15/2000CN1058500C Thymosin alpha-1 derivatives
11/15/2000CN1058487C 1,5-benzodiazepine derivatives having CCK antagoistic or agonistic activity
11/14/2000US6147212 Proline-naphthylalanine dipeptide amidated with an acyl derivative on the n-terminus and a 4-phenyl-1-piperazinyl derivative on the carboxyl terminus; neurokinin (tachykinin) antagonist
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/14/2000US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions
11/14/2000US6147201 Nucleotide sequences coding acarnia protein; for the diagnosis and treatment of sensitivity to acarnia allergy proteins
11/14/2000US6147200 2'-O-acetamido modified monomers and oligomers
11/14/2000US6147192 Proteins associated with weight control; for the treatmen of eating disorders
11/14/2000US6147191 Protein associated with mylein and the central nervous system; for the diagnosis and treatment of multiple sclerosis and autoimmune diseases
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147189 Biosynthesis of structurally confined protein; synthesize a protein with a tripeptide active position composed of arginine, glycine, asparagine and proline residues at terminals .
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147186 Receptor agonist for treating osteoporosis
11/14/2000US6147095 Administering combination of tipranavir and ritonavir for treatment of hiv
11/14/2000US6147073 Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147054 Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid
11/14/2000US6147053 Combination containing growth factors and polyelectrolytes
11/14/2000US6147052 Method of differentiating erythrocyte progenitor cells
11/14/2000US6147051 Antiischemic agent
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146888 Amplification of preferential cell population; mixing cells in which the genome codes an antibiotic resistance gene, recovering cells that propagate in the presence of antibiotic
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
11/14/2000US6146886 RNA polymerase III-based expression of therapeutic RNAs
11/14/2000US6146876 22025, a novel human cyclic nucleotide phosphodiesterase
11/14/2000US6146872 Cyclic lipopeptide acylase
11/14/2000US6146868 Nucleotide and amino acid sequence of enzyme which deacetylates component of fungal capsule; fungicides for treatment of cryptococcosis
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146852 Production of human parathyroid hormone from microorganisms
11/14/2000US6146851 DNA encoding NV2 (long form) and carboxy truncated fragments thereof
11/14/2000US6146850 Proteins encoding gelonin sequences
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146824 Method for determining tumor cell adhesion
11/14/2000US6146662 Dosage form of calcium channel blocker drug, and a polymer of given molecular weight and rate of hydration that changes the form from non-dispensable phase to a dispensable phase; and a drug-delayed delivery composition comprising a polymer
11/14/2000US6146658 Prodrugs, their preparation and use as pharmaceuticals
1 ... 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 ... 3163